Classification
- Anatomical main groupRRespiratory system
- Therapeutic subgroupR01
- Pharmacological subgroupR01A
- Chemical subgroupR01AD
- Chemical substanceR01AD12Fluticasone furoate
R03BA05
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 133 registrations
- AVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASAL27,5 µg · suspensión para pulverización nasal · Glaxo Group Limited
- Avamys 27,5 Microgramos/Pulverizacion, Suspension Para Pulverizacion Nasal27,5 µg · suspensión para pulverización nasal · Glaxosmithkline Trading Services Limited
- Avamys 27,5 Microgramos/Pulverizacion Suspension Para Pulverizacion Nasal27,5 µg · suspensión para pulverización nasal · Glaxo Group Limited
- Avancort 27,5 Microgramos/Pulverizacion Suspension Para Pulverizacion Nasal27,5 µg · suspensión para pulverización nasal · Laboratorios Cinfa S.A.
Canada
Health Canada · 61 registrations
At a glance
- ATC code
- R01AD12, R03BA05
- ATC group
- Respiratory system
- Registers
- 11
- Historical lists
- 2
- Registrations
- 462
- With their own page
- 326
- Companies
- 101
All medicines with Fluticasone
Human medicines from every register that match Fluticasone by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
462 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Fluticasone Propionate | United States | 0.05% | cream | Marketed | Padagis Israel |
| Fluticasone Propionate | United States | 0.044MG/INH | aerosol, metered | Marketed | Glenmark Speclt |
| Fluticasone Propionate | United States | 0.05MG/SPRAY | spray, metered | Marketed | Hikma |
| Fluticasone Propionate | United States | 0.05% | lotion | Marketed | Glenmark Pharms LTD |
| Fluticasone Propionate | United States | 0.005% | ointment | Marketed | Padagis Israel |
| Fluticasone Propionate and Salmeterol XinafoateCombination | United States | 0.1MG/INH; 0.05MG BASE/INH, 0.25MG/INH; 0.05MG BASE/INH, 0.5MG/INH; 0.05MG BASE/INH | powder | Marketed | Hikma |
| Apo-Fluticasone | Canada | 50 MCG / ACT | Spray (Metered-Dose) | Marketed | Apotex INC |
| Teva-Fluticasone | Canada | 50 MCG / ACT | Metered-Dose Pump | Marketed | Teva Canada Limited |
| PMS-Fluticasone | Canada | 250 MCG / ACT | Powder | Authorised | Pharmascience INC |
| PMS-Fluticasone | Canada | 500 MCG / ACT | Powder | Authorised | Pharmascience INC |
| PMS-Fluticasone | Canada | 100 MCG / ACT | Powder | Authorised | Pharmascience INC |
| Apo-Fluticasone HFA | Canada | 125 MCG / ACT | Aerosol (Metered-Dose) | Marketed | Apotex INC |
| Apo-Fluticasone HFA | Canada | 50 MCG / ACT | Aerosol (Metered-Dose) | Marketed | Apotex INC |
| Apo-Fluticasone HFA | Canada | 250 MCG / ACT | Aerosol (Metered-Dose) | Marketed | Apotex INC |
| PMS-Fluticasone HFA | Canada | 250 MCG / ACT | Aerosol (Metered-Dose) | Marketed | Pharmascience INC |
| PMS-Fluticasone HFA | Canada | 50 MCG / ACT | Aerosol (Metered-Dose) | Marketed | Pharmascience INC |
| PMS-Fluticasone HFA | Canada | 125 MCG / ACT | Aerosol (Metered-Dose) | Marketed | Pharmascience INC |
| Apo-Azelastine/FluticasoneCombination | Canada | 137 MCG / ACT + 50 MCG / ACT | Spray (Metered-Dose) | Marketed | Apotex INC |
| Mylan-Azelastine/FluticasoneCombination | Canada | 137 MCG / ACT + 50 MCG / ACT | Spray (Metered-Dose) | Marketed | Mylan Pharmaceuticals Ulc |
| Azelastine Hydrochloride and Fluticasone PropionateCombination | United States | 0.137MG/SPRAY; 0.05MG/SPRAY | spray, metered | Marketed | Apotex |
| PMS-Fluticasone Propionate/Salmeterol DpiCombination | Canada | 100 MCG / ACT + 50 MCG / ACT | Powder | Marketed | Pharmascience INC |
| PMS-Fluticasone Propionate/Salmeterol DpiCombination | Canada | 500 MCG / ACT + 50 MCG / ACT | Powder | Marketed | Pharmascience INC |
| PMS-Fluticasone Propionate/Salmeterol DpiCombination | Canada | 250 MCG / ACT + 50 MCG / ACT | Powder | Marketed | Pharmascience INC |
| Flovent HFA | United States | 0.044MG/INH, 0.11MG/INH, 0.22MG/INH | aerosol, metered | Marketed | Glaxo GRP LTD |
| Flovent Diskus 50 | United States | 0.05MG/INH | powder | Marketed | Glaxo GRP LTD |